Patent Number CA2096159 A1 1993-11-15
 
Peptides that induce antibodies which neutralize genetically divergent HIV-1 isolates
This invention refers to peptides binding to antibodies that show neutralizing activity against different strains and clinical isolates of HIV-1 and that inhibit the fusion of cells caused by HIV-1.These peptides are applied with an adjuvant, as recombinant fusion proteins, chemically coupled to carrier molecules, as recombinant chimeric viruses or as recombinant antibodies.

 ©Questel
FamPat family
Publication Number Type Publi.Date Links
  EP0570357 A2 1993-11-18
STG: (A2) Application published without search report
AP: 1993EP-0890100
  EP0570357 A3 1994-04-20
STG: (A3) Published search report
AP: 1993EP-0890100
  EP0570357 B1 1997-06-25
STG: (B1) Patent specification
AP: 1993EP-0890100
  US5693752 A 1997-12-02
STG: (A) Patents Granted before 2001-04-15
AP: 1994US-08361479
  US5756674 A 1998-05-26
STG: (A) Patents Granted before 2001-04-15
AP: 1995US-08473576
  US5866694 A 1999-02-02
STG: (A) Patents Granted before 2001-04-15
AP: 1997US-08843718
  DE570357 T1 1994-07-28
STG: (T1) Trans. of EP claims (EPTD)
AP: 1993DE-0890100
  DE69311764 D1 1997-07-31
STG: (D1) Grant (no unexamined application published) patent law 81
AP: 1993DE-6011764
  DE69311764 T2 1998-02-05
STG: (T2) Trans. of EP patent
AP: 1993DE-6011764
  JPH06-293797 A 1994-10-21
STG: (A) Published application
AP: 1993JP-0113007
  JP3369246 B2 2003-01-20
STG: (B2) Published granted patent (Second level) from 01-03-1996 onwards (Published examined patent application (Second level) 1971-1996)
AP: 1993JP-0113007
  CA2096159 A1 1993-11-15
STG: (A1) Application laid open
AP: 1993CA-2096159
  CA2096159 C 2004-07-20
STG: (C) Patent (second level)
AP: 1993CA-2096159
  ES2053413 T1 1994-08-01
STG: (T1) Transl. of the claims with drawings of European applications (former A4) from 1992
AP: 1993ES-0890100T
  ES2053413 T3 1997-11-16
STG: (T3) Translation of granted European patent (former B3)
AP: 1993ES-0890100T
First Date of Grant 1997-06-25
1997-12-02
1998-05-26
1999-02-02
1997-07-31
2003-01-20
1997-11-16
2004-07-20
Inventor KATINGER HERMANN
RUEKER FLORIAN
HIMMLER GOTTFRIED
MUSTER THOMAS
PURTSCHER MARTIN
MAIWALD GEORG
STEINDL FRANZ
TRKOLA ALEXANDRA
All applicant/assignee Polymun ScientificImmunbiologische Forschung GmbH ([AT])
Polymun ScientificImmunbiologische Forschung GmbH ([AT])
Polymun ScientificImmunbiologische Forschung GmbH ([AT])
Katinger Hermann ([AT])
Katinger Herman ([AT])
Katinger Hermann ([AT])
POLIMUN SCIENTIFIC IMMUNBIOLOGISCHE FORSCHUNGSGESELLSCHAFT MBH, WIEN, AT
POLYMUN SCIENTIFIC IMMUNBIOLOGISCHE FORSCHUNG GMBH, WIEN, AT
POLYMUN SCIENTIFIC IMMUNBIOLOGISCHE FORSCHUNG GMBH, WIEN, AT
HERUMAN KATSUTEINGAA
POLIMUN SCIENTIFIC IMMUNBIOLOGISCHE FORSCHUNGS GMBH
POLYMUN SCIENTIFIC IMMUNBIOLOGISCHE FORSCHUNG GMBH
KATINGER, HERMANN
RUKER, FLORIAN
HIMMLER, GOTTFRIED
MUSTER, THOMAS
TRKOLA, ALEXANDRA
PURTSCHER, MARTIN
MAIWALD, GEORG
STEINDL, FRANZ
KATINGER, HERMANN ([AT])
Priority Details 1992AT-0000987 1992-05-141992US-07932787 1992-08-291994US-08361479 1994-12-221995US-08473576 1995-06-071997US-08843718 1997-04-17
Designated States Contracting States: BE CH DE DK ES FR GB IE IT LI NL PT SE
   
©Questel